ADPT
NASDAQ
US
Adaptive Biotechnologies Corporation - Common Stock
$14,81
▲ +$0,38
(+2,63%)
Vol. 1.6M
7
Punteggio di Qualità
fail
Ricavi ✗
Utile netto ✗
>IPO ✗
Cap. mercato
$2.5B
ROE
-41,1%
Margine
-31,6%
D/E
64,49
Beta
2,18
52W
$6–$21
Consenso Wall Street
14 analisti · Apr 20265
Acquisto forte
7
Compra
2
Mantieni
0
Vendi
0
Vendita forte
85,7%
Rating Compra
Grafico dei Prezzi
Titoli simili
Utili
Tasso di battuta: 100,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | $-0,18 | $-0,09 | +$0,09 |
| Set 2025 | $-0,15 | $0,06 | +$0,21 |
| Giu 2025 | $-0,24 | $-0,17 | +$0,07 |
| Mar 2025 | $-0,30 | $-0,20 | +$0,10 |
Ricavi e utili trimestrali
| Trimestre | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Ricavi | — | $47.5M | $52.4M | $58.9M | $94.0M | $71.7M |
| Utile netto | — | -$33.7M | -$29.9M | -$25.6M | $9.5M | -$13.6M |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -61.0% | -60.9% | -60.9% | -60.9% | -41.1% | -41.1% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -43.5% | -59.1% | -59.1% | -59.1% | -31.6% | -31.6% |
| Gross Margin | 69.4% | 66.0% | 66.0% | 66.0% | 71.8% | 71.8% |
| D/E Ratio | 74.32 | 74.32 | 74.32 | 74.32 | 64.49 | 64.49 |
| Current Ratio | 2.84 | 2.84 | 2.84 | 2.84 | 3.38 | 3.38 |
Rapporti chiave
ROA (TTM)
-15,7%
P/S (TTM)
9,81
P/B
4,4
EPS (TTM)
$-0,54
CF/Share
$-1,21
Crescita ricavi 3A
+5,1%
52W High
$20,76
52W Low
$5,91
$5,91
Intervallo 52 settimane
$20,76
Salute finanziaria
Flusso di cassa libero
$1.4M
Debito netto
$8.7M
Liquidità
$70.5M
Debito totale
$79.1M
Aggiornato al Dic 31, 2025
Як ADPT виглядає на тлі конкурентів у Life Sciences Tools & Services?
Група порівняння: Small-cap Life Sciences Tools & Services ($300M+) · 25 компаній
Оцінка ADPT vs аналоги Life Sciences Tools & Services
P/E
—
▼
0%
sotto
peer
(32,5)
vs Peer
vs Settore
Valore equo
P/S
9,8
▲
157%
sopra
peer
(3,8)
vs Peer
vs Settore
Sopravvalutato
P/B
4,4
▲
17%
sopra
peer
(3,7)
vs Peer
vs Settore
Sopravvalutato
Дивідендна дохідність
—
▼
0%
sotto
peer
(0,5%)
vs Peer
vs Settore
Rendimento basso
Прибутковість ADPT vs аналоги Life Sciences Tools & Services
ROE
-41,1%
▼
1157%
sotto
peer
(-3,3%)
vs Peer
vs Settore
Debole
Net margin
-31,6%
▼
237%
sotto
peer
(-9,4%)
vs Peer
vs Settore
Debole
Валова маржа
71,8%
▲
50%
sopra
peer
(48,0%)
vs Peer
vs Settore
Top livello
ROA
-15,7%
▼
503%
sotto
peer
(-2,6%)
vs Peer
vs Settore
Debole
Фінансове здоровʼя ADPT vs аналоги Life Sciences Tools & Services
D/E ratio
64,5
▲
77%
sopra
peer
(36,5)
vs Peer
vs Settore
Sopra media
Поточна ліквідність
3,4
▼
0%
sotto
peer
(3,4)
vs Peer
vs Settore
In linea
Beta
2,2
▲
54%
sopra
peer
(1,4)
vs Peer
vs Settore
Più volatile
Радар фундаменталів ADPT
ADPT
Mediana peer
Industria
ADPT прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
ADPT vs аналоги: ключові метрики
Attività insider
NeutralAcquisti
0
Vendite
0
RUBINSTEIN JULIAN
President · Mar 23
44166 shs
RUBINSTEIN JULIAN
President · Mar 23
57180 shs
RUBINSTEIN JULIAN
President · Mar 18
44166 shs
RUBINSTEIN JULIAN
President · Mar 18
57180 shs
RUBINSTEIN JULIAN
President · Mar 13
44166 shs
RUBINSTEIN JULIAN
President · Mar 13
179703 shs
LO FRANCIS
Officer · Mar 11
30593 shs
BOBULSKY SUSAN
Officer · Mar 11
41338 shs
ROBINS HARLAN S.
Officer · Mar 11
470266 shs
GRIFFIN MICHELLE RENEE
Director · Mar 11
15394 shs
Ultimo 90 giorni
Principali azionisti
Top 5: 40,96%Viking Global Investors, L.…
19,48%
$372.2M
Blackrock Inc.
8,66%
$165.5M
Vanguard Group Inc
7,33%
$140.0M
Price (T.Rowe) Associates I…
2,85%
$54.4M
Westfield Capital Managemen…
2,64%
$50.4M
Aggiornato al Dic 31, 2025
Ultime notizie
Nessuna notizia correlata ancora